126 related articles for article (PubMed ID: 2338124)
21. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
Bhattacherjee P; Williams BS; Paterson CA
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
[TBL] [Abstract][Full Text] [Related]
22. Marked differential effects of prostanoid metabolites on rabbit intraocular pressure.
Woodward DF; Williams LS; Chen J
Ophthalmic Res; 1989; 21(6):428-35. PubMed ID: 2626239
[TBL] [Abstract][Full Text] [Related]
23. Ocular hypotensive effect of PhXA41 in patients with ocular hypertension or primary open-angle glaucoma.
Hotehama Y; Mishima HK; Kitazawa Y; Masuda K
Jpn J Ophthalmol; 1993; 37(3):270-4. PubMed ID: 8295364
[TBL] [Abstract][Full Text] [Related]
24. In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
Woodward DF; Chan MF; Cheng-Bennett A; Wheeler LA; Chen G; Burke JA; Kharlamb A; Lai RK; Shan T
Exp Eye Res; 1996 Oct; 63(4):411-23. PubMed ID: 8944548
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of PhXA34 and PhXA41, two novel prostaglandin F2 alpha-isopropyl ester analogues for glaucoma treatment.
Hotehama Y; Mishima HK
Jpn J Ophthalmol; 1993; 37(3):259-69. PubMed ID: 8295363
[TBL] [Abstract][Full Text] [Related]
26. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes.
Ziai N; Dolan JW; Kacere RD; Brubaker RF
Arch Ophthalmol; 1993 Oct; 111(10):1351-8. PubMed ID: 8216015
[TBL] [Abstract][Full Text] [Related]
27. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species.
Yousufzai SY; Ye Z; Abdel-Latif AA
Exp Eye Res; 1996 Sep; 63(3):305-10. PubMed ID: 8943703
[TBL] [Abstract][Full Text] [Related]
28. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function.
Toris CB; Camras CB; Yablonski ME; Brubaker RF
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S69-75. PubMed ID: 9154279
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
Ota T; Murata H; Sugimoto E; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
[TBL] [Abstract][Full Text] [Related]
30. Effects of topical PGF2 alpha on aqueous humor dynamics in cynomolgus monkeys.
Crawford K; Kaufman PL; Gabelt BT
Curr Eye Res; 1987 Aug; 6(8):1035-44. PubMed ID: 3478175
[TBL] [Abstract][Full Text] [Related]
31. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
Easthope SE; Perry CM
Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
[TBL] [Abstract][Full Text] [Related]
32. New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents.
Nakajima T; Matsugi T; Goto W; Kageyama M; Mori N; Matsumura Y; Hara H
Biol Pharm Bull; 2003 Dec; 26(12):1691-5. PubMed ID: 14646172
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin A2 increases uveoscleral outflow and trabecular outflow facility in the cat.
Toris CB; Yablonski ME; Wang YL; Hayashi M
Exp Eye Res; 1995 Dec; 61(6):649-57. PubMed ID: 8846836
[TBL] [Abstract][Full Text] [Related]
34. Intraluteal infusions of prostaglandins of the E, D, I, and A series prevent PGF2 alpha-induced, but not spontaneous, luteal regression in rhesus monkeys.
Zelinski-Wooten MB; Stouffer RL
Biol Reprod; 1990 Sep; 43(3):507-16. PubMed ID: 2271732
[TBL] [Abstract][Full Text] [Related]
35. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.
Toris CB; Camras CB; Yablonski ME
Ophthalmology; 1993 Sep; 100(9):1297-304. PubMed ID: 8371915
[TBL] [Abstract][Full Text] [Related]
36. The effects of prostaglandins on the blood-ocular barrier.
Kosaka T; Mishima HK; Kiuchi Y; Kataoka K
Jpn J Ophthalmol; 1995; 39(4):368-76. PubMed ID: 8926644
[TBL] [Abstract][Full Text] [Related]
37. Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension.
Camras CB; Schumer RA; Marsk A; Lustgarten JS; Serle JB; Stjernschantz J; Bito LZ; Podos SM
Arch Ophthalmol; 1992 Dec; 110(12):1733-8. PubMed ID: 1463414
[TBL] [Abstract][Full Text] [Related]
38. The effects of ocular hypotensive doses of PGF2 alpha-isopropylester on anterior segment morphology.
Lütjen-Drecoll E; Tamm E
Prog Clin Biol Res; 1989; 312():437-46. PubMed ID: 2678149
[TBL] [Abstract][Full Text] [Related]
39. The effect of prostaglandin F2 alpha-1-isopropylester (PGF2 alpha-IE) on uveoscleral outflow.
Nilsson SF; Sperber GO; Bill A
Prog Clin Biol Res; 1989; 312():429-36. PubMed ID: 2678148
[TBL] [Abstract][Full Text] [Related]
40. The effect of topical PGF2 alpha on uveoscleral outflow and outflow facility in the rabbit eye.
Poyer JF; Gabelt B; Kaufman PL
Exp Eye Res; 1992 Feb; 54(2):277-83. PubMed ID: 1559555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
